5Darson MF, Pacelli A, Roche P, et al. Human glandular kall ikrein2 ( hk2 ) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prost ate cancer marker[J]. Urology, 1997, 49 ( 6 ) : 857-862.
7Becker C, Piironen T, Pett ersson K, et al. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein2 (hk2) in serum[J]. J Urol, 2000, 163 (1) :311-316.
8Busse markers M J, van Bokhoven A, Verhaegh GW, et al. DD3: a new prostate specific gene, highly over expressed in prostate cancer[J]. Cancer Res, 1999, 59 ( 23 ) : 5975-5979.
9Hessels D, Klein Gunnewiek JM, van Oort Iet al. DD3 ( PCA3 ) -based molecular urine analysis for the diagnosis of prostate cancer[J]. Eur Urol, 2003, 44 ( 1 ) : 8-16.
10Lin Y, Uemura }4, Fujinami K, et al. Telomerase activity in primary prostate cancer[J]. J Urol, 1997, 157:1161.
4Zhang L, Ji G, Li X, et al. fPSA/tPSA ratio optimize the early diagnosis is in the prostate cancer[J]. Chin J Androl, 2004, 10 (8) :582- 586.
5Khan MA, Sokoll LJ, Chan DW, et al. Clinical utility of proPSA and "benign" PSA when percent flee PSA is less than 15% [J]. Urology, 2004, 64(6) :1160-1164.
6Gu Z, Thomas G, Yamashiro J, Shintaku IP, et al. Prostate stem cell antigen ( PSCA ) expression increases with high gleason score [ J ]. Advanced stage and bone metastasis in prostate cancer, 2000, 19: 1288- 1296.
7hi gang Z, Wenlv 5. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: Implications for prostate carcinogenesis and progression of prostate cancer[J]. Japan J Clin Oncol, 2004,34:7.
8Xiao Z, Adam BL, Cazares LH, et al. Quantitation of serum prosrate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease[ J]. Cancer Res, 2001, 61(16) : 6029-6033.
9Kurek R, Nunez G, Tselis N, et al. Prognostic value of combined "triple"-reverse transcription-PGR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients [ J ]. Clin Cancer Ros, 2004, 10(17) : 5808-5814.
10Stearns ME, Wang M, Garcia FU, et al. Evidence for prostate cancer-associated diagnostic marker-1 : immunohistochemistry and in situ hybridization studios[J]. Clin Cancer Res, 2004, 10(7) : 2452-2458.
